Abstract | BACKGROUND: OBJECTIVE: METHODS: RESULTS:
Calcitonin gene-related peptide (CGRP) is released from the trigeminal ganglion and dura mater. In contrast, PACAP is only released from the trigeminal ganglion. We observed a weak correlation between the stimulated release of the two neuropeptides. PACAP-38 immunoreactivity was expressed alone and in a subpopulation of neurons in the trigeminal ganglion that also store calcitonin gene-related peptide. The receptor subtype PAC1 was mainly expressed in the satellite glial cells (SGCs), which envelop the neurons in the trigeminal ganglion, in some neuronal processes, inside the Aδ-fibres and in the outermost layer of the myelin sheath that envelopes the Aδ-fibres. CONCLUSION: Unlike CGRP, PACAP is only released within the trigeminal ganglion. This raises the question of whether a migraine therapy aimed at preventing peripheral PACAP signalling would be as successful as the CGRP signalling targeted treatments.
|
Authors | Jacob Carl Alexander Edvinsson, Anne-Sofie Grell, Karin Warfvinge, Majid Sheykhzade, Lars Edvinsson, Kristian Agmund Haanes |
Journal | Cephalalgia : an international journal of headache
(Cephalalgia)
Vol. 40
Issue 12
Pg. 1296-1309
(10 2020)
ISSN: 1468-2982 [Electronic] England |
PMID | 32486909
(Publication Type: Journal Article)
|
Chemical References |
- Pituitary Adenylate Cyclase-Activating Polypeptide
- Calcitonin Gene-Related Peptide
|
Topics |
- Animals
- Calcitonin Gene-Related Peptide
(metabolism)
- Dura Mater
(metabolism)
- Male
- Migraine Disorders
(physiopathology)
- Pituitary Adenylate Cyclase-Activating Polypeptide
(metabolism)
- Rats
- Rats, Sprague-Dawley
- Trigeminal Ganglion
(metabolism)
|